Economy · Full coverage
More layoffs possible? After Ramat Hovav, Teva's Kfar Saba plant is in the crosshairs
How 5 Israeli newsrooms covered this story — translated into English and compared side by side.
50% center
Center 1Right 1Unrated 3
First reported by TheMarker · Jun 10, 2026
What happened
Teva employees in Kfar Saba fear hundreds of additional layoffs after the company cut 250 jobs at its Ramat Hovav site. A source close to Teva said management may move generic tablet production abroad, while the sterile segment would remain in Kfar Saba. The report also says Trima in Ma'abarot is set to close and Katzat may be sold to Dexel.
Summary translated & synthesized from the sources below by baba. Read each original for the full report.
Full coverage · 5 outlets
The same event, reported separately by each newsroom. Open a few to compare what each emphasizes — and what they leave out.
Related stories
German Merck Group Shuts Two Israeli R&D Centers, Lays Off All EmployeesJul 17, 2026600 Workers to Lose Jobs as Nahariya Blade-Technology Plant ClosesJun 16, 2026Kibbutz Maabarot Shuts Down Terima Pharmaceutical Company After 85 YearsJul 27, 2026Teva Reports Higher-Than-Expected Q2 Revenue but Misses Profit EstimatesJul 29, 2026Tnuva Shuts Down Olivia Spread Production Plant After Decades in IsraelAug 6, 2026Teva Shares Continue Decline Amid Market Volatility and Sector ComparisonsJul 19, 2026
